Zober A, Will W
Occupational Medical and Health Protection Department, BASF Aktiengesellschaft, Ludwigshafen, Germany.
Int Arch Occup Environ Health. 1996;68(6):389-93. doi: 10.1007/BF00377857.
In summary, we have found biomonitoring to be a valuable adjunct to medical surveillance in a number of situations. Although the potential benefits are relatively easy to demonstrate, clear guidance must be provided to assure that no harm will result from a biomonitoring program. A critical step in this regard is attention to the communication of objectives and results. This is especially true where biomonitoring of carcinogenic substances or surrogate measures for these substances are being considered. In such situations, action levels are helpful for interpretative purposes and immediate decision-making, but not for determining individual health risks. However, the quantitative results may be suitable for use in future health studies and risk assessments.
总之,我们发现在许多情况下,生物监测是医学监测的一项有价值的辅助手段。虽然潜在益处相对容易证明,但必须提供明确的指导,以确保生物监测计划不会造成危害。在这方面的关键一步是关注目标和结果的沟通。在考虑对致癌物质或这些物质的替代指标进行生物监测时尤其如此。在这种情况下,行动水平有助于解释目的和即时决策,但不适用于确定个体健康风险。然而,定量结果可能适用于未来的健康研究和风险评估。